Participate in Research

Browse Clinical Trials
Vaccine Study for Healthy Adults
Protocol: STUDY00007111
Full Title
The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responses
Description
The University at Buffalo (UB) Department of Microbiology and Immunology is looking for healthy adults aged 21 – 40 or above 60 years old for a vaccine study. The goal of this study is to see how age plays a role in a person’s bodily response to a vaccine (Prevnar-20) that will protect against pneumococcal pneumonia.

Eligible participants will complete 3 study visits over 1 month at the UB Clinical and Translational Research Center (875 Ellicott Street in Buffalo). Visit 1 will involve a blood draw, the vaccine administration, and paperwork. Visit 2 will occur 1 week later and will include a blood draw. Visit 3 will occur 1 month later and include a blood draw. Participants will be paid $50 per study visit.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
Healthy adults aged 21-40 OR above 60 years old
Have not received the pneumococcal pneumonia vaccine
Are not currently pregnant
Have not been diagnosed with dementia
Fluent in English
Age Group: Adults
Principal Investigator: Elsa Bou Ghanem
Contact(s)
CATHERINE WRONA
wrona@buffalo.edu
+1 716-888-4713
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login